Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingolf Cascorbi

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
Deutsches Arzteblatt International|November 9, 2018
The Neurophysiology and Treatment of Motion SicknessAndreas Koch, Ingolf Cascorbi, Martin Westhofen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 25, 2016
Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanismUlf Lützen, Yi Zhao, Katja Lucht, et al.
Frontiers in Pharmacology|June 5, 2023
Pharmacogenomics in practice: a review and implementation guideDanya Kabbani, Reem Akika, Ahmed Wahid, et al.
Pharmacogenetics|August 2, 2003
Functional significance of a hereditary adenine insertion variant in the 5'-UTR of the endothelin-1 geneKatrin Popowski, Bernhard Sperker, Heyo K Kroemer, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypesMikko Niemi, Ingolf Cascorbi, Ramona Timm, et al.
Science (New York, N.Y.)|February 2, 2019
Plan S: A threat to quality of science?Michael Spedding, James Barrett, Edward T Morgan, et al.
European Journal of Clinical Pharmacology|September 19, 2003
Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucomaKivanc Güngör, Mehtap Ozkur, Ingolf Cascorbi, et al.
The Journal of Biological Chemistry|June 6, 2012
Differential expression and functionality of TRPA1 protein genetic variants in conditions of thermal stimulationDenisa May, Jonas Baastrup, Maria Raphaela Nientit, et al.
Molecular Pharmacology|November 24, 2019
Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA RegulationOliver Bruhn, Marie Lindsay, Friederike Wiebel, et al.
Experimental Hematology & Oncology|October 1, 2020
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistanceTheresa Klümper, Henrike Bruckmueller, Tobias Diewock, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
Deutsches Arzteblatt International|November 9, 2018
The Neurophysiology and Treatment of Motion SicknessAndreas Koch, Ingolf Cascorbi, Martin Westhofen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 25, 2016
Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanismUlf Lützen, Yi Zhao, Katja Lucht, et al.
Frontiers in Pharmacology|June 5, 2023
Pharmacogenomics in practice: a review and implementation guideDanya Kabbani, Reem Akika, Ahmed Wahid, et al.
Pharmacogenetics|August 2, 2003
Functional significance of a hereditary adenine insertion variant in the 5'-UTR of the endothelin-1 geneKatrin Popowski, Bernhard Sperker, Heyo K Kroemer, et al.
Clinical Pharmacology and Therapeutics|September 18, 2002
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypesMikko Niemi, Ingolf Cascorbi, Ramona Timm, et al.
Science (New York, N.Y.)|February 2, 2019
Plan S: A threat to quality of science?Michael Spedding, James Barrett, Edward T Morgan, et al.
European Journal of Clinical Pharmacology|September 19, 2003
Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucomaKivanc Güngör, Mehtap Ozkur, Ingolf Cascorbi, et al.
The Journal of Biological Chemistry|June 6, 2012
Differential expression and functionality of TRPA1 protein genetic variants in conditions of thermal stimulationDenisa May, Jonas Baastrup, Maria Raphaela Nientit, et al.
Molecular Pharmacology|November 24, 2019
Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA RegulationOliver Bruhn, Marie Lindsay, Friederike Wiebel, et al.
Experimental Hematology & Oncology|October 1, 2020
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistanceTheresa Klümper, Henrike Bruckmueller, Tobias Diewock, et al.
Pageof 20